Established in August 2020, IMBiologics Co., Ltd. is a South Korean biotechnology company specializing in the development of innovative immunomodulatory antibody therapeutics. The company's mission is to restore physiological balance, or homeostasis, in patients by developing novel biologics that modulate immune responses.

Immunomodulatory Antibody Development: IMBiologics focuses on creating antibodies that can modulate the immune system to treat various diseases, including autoimmune disorders and cancers. Their proprietary platform technology accelerates the research and development process of these innovative therapeutics.

Private

Biotech